IO Biotech announced the appointment of Heidi Hunter to its board of directors. Hunter will serve on the Audit Committee and the Nominating and Corporate Governance Committee of the Board. Hunter most recently served as President of Cardinal Health where she led the Specialty Solutions Business.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IOBT:
- IO Biotech Announces 2023 Second Quarter Results
- IO Biotech Appoints Heidi Hunter to its Board of Directors
- IO Biotech Announces Abstract Accepted for Poster Presentation at ESMO Congress 2023
- IO Biotech to sell 37.07M shares at $2.025 in private placement
- IO Biotech, Inc. Announces $75 Million Private Placement Financing
